middle.news
INOVIQ Commits to Review After EXO-OC Sample Quality Issues
9:49am on Tuesday 14th of July, 2026 AEST
•
Healthcare
Read Story
INOVIQ Commits to Review After EXO-OC Sample Quality Issues
9:49am on Tuesday 14th of July, 2026 AEST
Key Points
Sample quality issues limit EXO-OC test evaluation
Technical review and biomarker refinement underway
Dual LDT and IVD commercialisation paths confirmed
Board oversight and management accountability detailed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE